Prosecution Insights
Last updated: October 27, 2026
Application No. 18/653,382

MOTOR ASSEMBLY WITH HEAT EXCHANGER FOR CATHETER PUMP

Final Rejection §103
Filed
May 02, 2024
Priority
Jan 22, 2015 — provisional 62/106,675 +5 more
Examiner
LAU, MICHAEL J
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
TC1 LLC
OA Round
2 (Final)
72%
Grant Probability
Favorable
3-4
OA Rounds
4m
Est. Remaining
96%
With Interview

Examiner Intelligence

Grants 72% — above average
72%
Career Allowance Rate
235 granted / 325 resolved
+2.3% vs TC avg
Strong +23% interview lift
Without
With
+23.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
32 currently pending
Career history
363
Total Applications
across all art units

Statute-Specific Performance

§101
12.5%
-27.5% vs TC avg
§103
54.8%
+14.8% vs TC avg
§102
5.3%
-34.7% vs TC avg
§112
21.2%
-18.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 325 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments Applicant's arguments filed 9/14/2026 have been fully considered but they are not persuasive. Applicant argued that the provisional patent of the Muller reference does not disclose a motor with a damper. The Examiner respectfully disagrees. The provisional patent 61/979952 discloses a motor (eg. Para. 45, 71-78 with the damper O-ring 255 to reduce noise when pump is operating). The way the claims are written does not require the damper to be inside the motor, just that the motor includes at least one damper. One of ordinary skill could have rearranged the parts to have the O-ring at various locations since rearranging the parts would not have modified the function of reducing noise or vibrations as stated in Muller (eg. Para. 45, 71-78) (see MPEP 2144.04.IV.C). The 103 rejection is maintained below. Terminal Disclaimer The terminal disclaimer filed on 9/14/2026 disclaiming the terminal portion of any patent granted on this application which would extend beyond the expiration date of 9675739, 9987404, 10737005, 11633586, and 11998729 has been reviewed and is accepted. The terminal disclaimer has been recorded. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 21-40 is/are rejected under 35 U.S.C. 103 as being unpatentable over Campbell (US 9138518 B2) in view of Muller (US 2015/0290371 A1). Regarding claim 21, Campbell discloses a catheter pump system (eg. Fig. 1), comprising: a catheter assembly including an impeller assembly adapted to be percutaneously insertable within a vasculature of a heart patient (eg. Col, 4, Ln. 20-39); and a motor causing the impeller assembly to pump blood in a desired location in the vasculature (eg. Col. 3, Ln. 29 – Col. 5, Ln. 17), wherein the motor includes: a stator (eg. Col. 4, Ln. 39-51, Col. 5, Ln. 3-17, Col. 15, Ln. 35-46, magnet Fig. 11-12); a rotor disposed radially with the stator assembly (eg. Fig. 11-12 Col. 4, Ln. 39-51, Col. 5, Ln. 3-17, Col. 15, Ln. 35-46, rotor 470): an output shaft (Eg. Col. 15, Ln. 25-46); but does not disclose at least one damper configured to reduce a transmission of vibration while the percutaneously insertable impeller assembly is pumping blood in the performance of a heart procedure. Muller teaches a catheter pump system that has a damper between the drive and the drive member to reduce noise (eg. Para. 19-21, 80-81). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have combined the invention of Campbell with the dampener as taught by Muller since both references are related to catheter pumps and the dampener is used to provide the predictable result of reducing the noise at and around the connection between the drive and drive members (eg. Muller, Para. 20). Regarding claim 22, the combined invention of Campbell and Muller discloses the motor further includes a housing and at least one mounting flange coupled to the housing, the at least one damper provided on the at least one mounting flange (eg. Campbell, Col. 15, Ln. 25-35, Col. 21, Ln. 28 – Col. 22, Ln. 5, drive housing, Muller, Para. 69, 74-76). Regarding claim 23, the combined invention of Campbell and Muller discloses the at least one mounting flange includes an inner flange portion and an outer flange portion, the inner flange portion radially spaced apart from the outer flange portion and defining an annular gap (eg. Campbell, Col. 8, Ln. 66 – Col. 9, Ln. 36, annular space 274 with outer surface 278, Muller, Para. 19-21, 80-81 disposed between separate housings and radially outside housing as an O-ring). Regarding claim 24, the combined invention of Campbell and Muller discloses the at least one damper is disposed within the annular gap (eg. Muller, Para. 19-21, 80-81, O-ring, it would have been obvious to one of ordinary skill to have modified the O-rings to be in an annular ring to provide the predictable result of dampening vibrations between any parts as desired). Regarding claim 25, the combined invention of Campbell and Muller discloses at least one damper includes a rubber material (eg. Muller, Para. 81 visco-elastic or elastic polymer). Regarding claim 26, the combined invention of Campbell and Muller discloses the at least one damper includes a elastomer material (eg. Muller, Para. 81 visco-elastic or elastic polymer). Regarding claim 27, the combined invention of Campbell and Muller discloses at least one damper includes a polymer material (eg. Muller, Para. 81 visco-elastic or elastic polymer). Regarding claim 28, the combined invention of Campbell and Muller discloses at least one damper includes a spring (eg. Muller, Para. 81 visco-elastic or elastic polymer, a spring acts like an elastic material and would be an obvious alternative). Regarding claim 29, the combined invention of Campbell and Muller discloses the at least one damper includes a grommet disposed about the catheter assembly in a spaced relation from the at least one mounting flange, wherein the grommet reduces mechanical vibration of a drive shaft for the percutaneously insertable impeller assembly (eg. Muller, Para. 19-21, 80-81, O-ring basically functions as a grommet). Regarding claim 30, the combined invention of Campbell and Muller discloses at least one damper includes a first damper and second damper spaced apart from one another (eg. Muller, Para. 19-21, 80-81, can be put on multiple locations). Regarding claim 31, the combined invention of Campbell and Muller discloses the first damper and the second damper are respectively associated with first and second motor mounting flanges eg. Muller, Para. 19-21, 80-81, Muller teaches damper on the cap/housing interface and another around the motor, one of ordinary skill would have been able to rearrange the O rings onto Campbell’s motor mounting structures eg. Col. 15, Ln. 25-35, to provide the predictable result of reducing vibration at each location). Regarding claim 32, the combined invention of Campbell and Muller discloses the rotor extends between the first and second motor mounting flanges (eg. Campbell, Col. 15, Ln. 25-40, Muller, Para. 85). Regarding claim 33, the combined invention of Campbell and Muller discloses a flow diverter defining a chamber, and the rotor extending in the chamber (Eg. Col. 9, Ln. 35-50, Col. 21, Ln. 48 – Col. 22, Ln. 55). Regarding claim 34, the combined invention of Campbell and Muller discloses the first damper and the second damper extend radially in the respective first and second motor mounting flanges (eg. Campbell, Col. 8, Ln. 66 – Col. 9, Ln. 36, annular space 274 with outer surface 278, Muller, Para. 19-21, 80-81 disposed between separate housings and radially outside housing as an O-ring, one of ordinary skill would have been able to put the damper to extend radially in the motor flanges to provide spaced damping). Regarding claim 35, the combined invention of Campbell and Muller discloses the motor is located outside the vasculature of the heart patient while the percutaneously insertable impeller assembly is pumping blood (eg. Campbell, Col. 4, Ln. 39-51). Regarding claim 36, the combined invention of Campbell and Muller discloses a drive shaft extending through the catheter assembly, wherein the drive shaft interconnects the motor output shaft and the percutaneously insertable impeller assembly (eg. Col. 4, Ln. 65 – Col. 5, Ln. 17, Col. 13, Ln. 30-51, Col. 31, Ln. 35-65). Regarding claim 37, the combined invention of Campbell and Muller discloses the at least one damper includes a first damper operable to attenuate a mechanical vibration of the drive shaft (eg. Muller, Para. 19-21, 80-81, the damper is capable of reducing vibration). Regarding claim 38, the combined invention of Campbell and Muller discloses the first damper is a grommet eg. Muller, Para. 19-21, 80-81, O-ring basically functions as a grommet). Regarding claim 39, the combined invention of Campbell and Muller discloses at least one damper further includes a second damper operable to reduce a mechanical vibration of the motor (eg. Muller, Para. 19-21, 80-81, the damper is capable of reducing vibration). Regarding claim 40, the combined invention of Campbell and Muller discloses the second damper reduces a mechanical vibration of a motor housing (eg. Muller, Para. 19-21, 80-81, the damper is capable of reducing vibration). Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHAEL J LAU whose telephone number is (571)272-2317. The examiner can normally be reached 8-5:30 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Hamaoui can be reached at 5712705625. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MICHAEL J LAU/Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

May 02, 2024
Application Filed
May 12, 2026
Non-Final Rejection mailed — §103
Sep 14, 2026
Response Filed
Oct 08, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12758348
UNIVERSAL TRACKING ARRAY APPARATUS
2y 9m to grant Granted Oct 13, 2026
Patent 12740738
NONINVASIVE CARDIOVASCULAR EVENT DETECTION
3y 5m to grant Granted Sep 22, 2026
Patent 12741143
ELECTRIC STIMULATION METHOD BASED ON INSPIRATION OF HEALTHY SIDE LOWER LIMB MUSCLE SYNERGY AND SYSTEM THEREOF
2y 6m to grant Granted Sep 22, 2026
Patent 12733860
MULTI-STREAM BIOLOGICAL SIGNAL PROCESSING
1y 5m to grant Granted Sep 15, 2026
Patent 12721565
AUTOMATED TOOL FOR VEIN SHAVING IN ANATOMICAL MAP
2y 6m to grant Granted Sep 01, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
72%
Grant Probability
96%
With Interview (+23.2%)
2y 10m (~4m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 325 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month